bis(helenalinyl)malonate has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaney, SG; Hall, IH; Lee, KH; Liou, YF; Williams, WL | 1 |
| Chaney, SG; Grippo, AA; Hall, IH; Holbrook, DJ; Lee, KH; Oswald, CB; Williams, WL | 1 |
2 other study(ies) available for bis(helenalinyl)malonate and Leukemia P388
| Article | Year |
|---|---|
Investigation of sesquiterpene lactones as protein synthesis inhibitors of P-388 lymphocytic leukemia cells.
Topics: Animals; Antineoplastic Agents; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred DBA; Neoplasm Proteins; Poly U; Protein Biosynthesis; Sesquiterpenes; Sesquiterpenes, Guaiane; Terpenes | 1983 |
Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; DNA, Neoplasm; IMP Dehydrogenase; In Vitro Techniques; Leukemia P388; Leukemia, Experimental; Male; Mice; Neoplasm Proteins; RNA, Neoplasm; Sesquiterpenes; Sesquiterpenes, Guaiane; Terpenes; Thioredoxins | 1988 |